Author: Dr. David Lowemann

Obesity Drug Gets Medicare Coverage for Sleep Apnea

Eli Lilly’s popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, the Centers for Medicare & Medicaid Services said on Wednesday. Zepbound in December became the first drug approved in the U.S. for sleep apnea, but commercial insurers and… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on January 8, 2025

Elderberry juice shows benefits for weight management, metabolic health

Elderberry juice may be a potent tool for weight management and enhancing metabolic health, according to a recent study. A clinical trial found that drinking 12 ounces of elderberry juice daily for a week causes positive changes in the gut microbiome and improves glucose tolerance and fat oxidation. Read Full Article (External Site) Dr. David […]

Published on January 8, 2025

Illusion, dilution, or loss: psychological ownership and GenAI

Generative artificial intelligence (GenAI) reshapes and challenges psychological ownership of created content. This article examines how GenAI disrupts original content creators’ and GenAI users’ sense of ownership and control and illustrates how both can perceive the illusion, dilution, and potential loss of control and ownership of content in the GenAI era. Read Full Article (External […]

Published on January 8, 2025